Section 3: Drug discovery
Devoted to the advancement of innovative technologies for drug design and screening
In particular in silico screening technologies involving AChBP as well as screening on the 5HTR3 were employed. Lead compounds from the screens will be followed up in the coming year. In addition the use of different screening technologies (section 2) were aligned with drug screening in this section.
Overall, new technologies were established with the first promising results on small molecules targeting the different members of the CLR family.